Jim Denike

Biography

 Jim DeNike is the Senior Director of Corporate Development & Investor Relations at Nohla. In this role, Mr. DeNike oversees corporate-wide internal and external communications and is the primary contact for the investment community. Throughout his 25-year career in communications and investor relations working for both public and private companies, Mr. DeNike has provided strategic oversight on matters affecting corporate visibility and reputation. Prior to Nohla, he served since 2013 as the Senior Director, Corporate Communications and Investor Relations at OncoGenex Pharmaceuticals, Inc., a public company developing therapeutics addressing treatment resistance in cancer (now Achieve Life Sciences). Before joining OncoGenex, Mr. DeNike served as the Senior Director, Corporate Communications & Investor Relations for Trubion since 2006, and continued to serve as the Senior Director of Corporate Affairs following Trubion’s acquisition by Emergent BioSolutions. Prior to Trubion, Mr. DeNike created and led the role of corporate communications and investor relations for Corixa, a Seattle-based immunotherapy company. In addition to his extensive experience in life sciences, Mr. DeNike began his career working for leading technology PR agencies supporting clients such as Microsoft, HP, 3com and Polycom. Mr. DeNike holds a B.S. in Public Relations from San Jose State University.

Research Interest

finance